Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Labogroup is a Swiss-based international group specializing in the research, development, and commercialization of innovative dermo-cosmetic products. The company is best known for its flagship brands, Fillerina and Crescina, which utilize patented transdermic technology to deliver active ingredients like hyaluronic acid and amino acids deep into the skin and scalp. Labogroup focuses on non-invasive alternatives to aesthetic medicine procedures, such as needle-free fillers and hair regrowth treatments. With a strong emphasis on intellectual property, the company holds numerous patents worldwide and operates through a network of international distributors. Their research is centered on the penetration of medicinal molecules through the skin layers without injections, bridging the gap between traditional cosmetics and medical treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Labogroup Holding.